peptide-solutions

GLP3-RT

Triple-action GLP-1/GIP/Glucagon receptor agonist

Research Compound

Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.

Purity: >98%Form: LyophilizedStorage: -20°CGrade: Research

Top Seller

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Research highlights its potential for metabolic syndrome and obesity.

Compound Specifications

Purity Level>98%

Physical FormLyophilized powder (10mg/vial)

1. Choose dose

Select the amount contained in each vial.

2. Choose quantity option

Choose one vial, or choose a kit with 10 units priced as 8.

$125USD

Amount per vial: 10mg

3. Cart quantity:

Research-Grade

COA Available

Tracked Shipping

Third-Party Tested

Scientific Documentation

Research Reference

Detailed research information, pharmacological profile, and handling specifications

Mechanism of Action

Retatrutide activates GLP-1R for appetite suppression and glycemic control, GIPR for enhanced insulin secretion and fat metabolism, and GcgR for increased energy expenditure — creating synergistic metabolic effects.

Verified Buyer Reviews

What researchers say

Loading reviews...

Research Use Only Disclaimer

This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.